Lamotrigine
Product Images NDC 53002-2512

7 FDA label images from Rpk Pharmaceuticals, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Lamotrigine (NDC 53002-2512). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (6b93b93c 685b 4ca0 8663 A9e90273c423 740 1)

FDA Label Image

Image (6b93b93c 685b 4ca0 8663 A9e90273c423 789 2)

Image (6b93b93c 685b 4ca0 8663 A9e90273c423 789 2)
Lamotrigine tablets in multiple strengths and shapes: 25 mg white oval tablets marked with 'U 111', 100 mg white triangular tablets marked with 'U 112', 150 mg white triangular tablets marked with 'U 113', and 200 mg light blue triangular tablets marked with 'U 114'. Labeler is RPK Pharmaceuticals, Inc.*
FDA Label Image

Image (6b93b93c 685b 4ca0 8663 A9e90273c423 789 3)

FDA Label Image

Molecular Structure (Ad7af627 Ea4b 4a78 A71e Db1255416d1e 01)

Molecular Structure (Ad7af627 Ea4b 4a78 A71e Db1255416d1e 01)
Chemical structure of lamotrigine, showing a chlorinated phenyl ring attached to a triazine ring with two amino groups.*
FDA Label Image

Figure 1 (Ad7af627 Ea4b 4a78 A71e Db1255416d1e 02)

Figure 1 (Ad7af627 Ea4b 4a78 A71e Db1255416d1e 02)
A Kaplan-Meier plot showing failure probability (%) on the y-axis over time in weeks on the x-axis. Two curves compare Placebo and Lamotrigine, with censored data points indicated, illustrating differences in failure probabilities over approximately 100 weeks.*
FDA Label Image

Figure 2 (Ad7af627 Ea4b 4a78 A71e Db1255416d1e 03)

Figure 2 (Ad7af627 Ea4b 4a78 A71e Db1255416d1e 03)
A Kaplan-Meier failure probability plot comparing Lamotrigine and Placebo over approximately 80 weeks. The y-axis shows failure probability as a percentage from 0 to 100, and the x-axis shows duration in weeks. The graph includes censored data points indicated by plus signs, with separate survival curves labeled for Lamotrigine and Placebo groups.*
FDA Label Image

Label Image (Lbl530022512)

Label Image (Lbl530022512)
Lamotrigine 100mg tablets packaging label by RPK Pharmaceuticals, Inc. The label states the strength as 100mg and includes instructions to take as directed. It displays quantity as 100 tablets and features barcode, lot, and expiration information along with statements for prescription use, storage, and disposal. Placeholder text appears for clinic names and prescription details.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.